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Abstract
Background: To elucidate the clinical features of strabismus associated with IgG4-related ophthalmic disease (IgG4-ROD).
Case summary: All of the four patients with IgG4-ROD showed marked enlargement of the extraocular muscles,
however, two patients showed orthotropia with full ductions and versions. One patient showed a small angle of
exotropia and hypertropia of less than 5 prism diopters. One remaining patient showed orthotropia, full ductions
and versions despite marked enlargement of the extraocular muscles, then developed hypertropia up to 35 prism
diopters with activation of inflammation, which promptly improved after treatment with oral steroids.
Conclusions: IgG4-ROD usually shows normal ocular motility despite extraocular muscle enlargement, which is
the key distinguishing feature from other orbital inflammatory diseases. Active flare-up with increased serum IgG4
levels may produce a large angle of eye deviation, but mostly respond well to steroid treatment.
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Background
IgG4-related disease (IgG4-RD) is an immune-mediated
systemic condition characterized by enlargement of af-
fected organs caused by lymphoplasmacytic infiltration
with a predominance of IgG4-positive plasma cells
[1–3]. IgG4-related ophthalmic diseases (IgG4-ROD) is
defined when IgG4-RD involves orbital or ocular adnexal
apparatus, lacrimal gland, orbital soft tissue, sclera, and
extraocular muscles [4–6]. There have been many reports
of the involvement of extraocular muscles [5, 7–15], how-
ever, most of them are case reports or review articles, and
detailed clinical aspects regarding ocular motility associ-
ated with IgG4-ROD have been scarcely reported. Kubota
et al. [9] first reported the involvement of extraocular
muscles. One out of 10 patients with IgG4-RD showed
extraocular muscle involvement without diplopia, how-
ever there was no description about ocular motility. As
one of the large series, Plaza et al. [15] presented three out
of 11 patients with IgG4-RD including a first patient with
lateral rectus involvement, the second with medial
and lateral rectus muscles, and the third with extrao-
cular muscles. Only one patient complained of diplo-
pia. There was no description about ocular motility in
all three patients. As the largest series, Hardy et al.
[10] reported 14 IgG4-ROD patients with extraocular
muscle involvement, and 4 of them showed restricted
ocular motility. They described three patients of
which only one showed diplopia and mildly limited
abduction. Other than the case description, they did
not mention about the presence of diplopia or ocular
motility. The purpose of this report was to present
the detailed clinical features of ocular motility associ-
ated with IgG4-ROD.
Case presentation
A retrospective review of ophthalmologic examinations
and MR imaging findings was performed on four pa-
tients who visited the Department of Ophthalmology,
Seoul National University Bundang Hospital between
the years 2004 to 2014 and were confirmed to have
extraocular muscles affected by IgG4-ROD. IgG4-ROD
was diagnosed based on the diagnostic criteria for defin-
ite or probable IgG4-ROD proposed by Goto et al. [16]
The diagnosis was made when at least two of the three
following conditions were met; 1) enlargement of
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ophthalmic tissue in imaging study 2) IgG4+/IgG+
ratio > 40%, or IgG4+ cells > 50/HPF in histopathologic
examination 3) serum IgG4 > 135 mg/dl. Patients with
cranial nerve III, IV, or VI palsy, Brown syndrome,
Duane retraction syndrome, other restrictive strabismus,
or unilateral extraocular muscle fibroma localized to one
muscle were excluded. The study protocol was approved
by the institutional review board of Seoul National
University Bundang Hospital.
Ophthalmologic examinations of ductions and ver-
sions together with alternate prism cover tests at 6 car-
dinal gazes were performed. Computed tomography
(CT) imaging was conducted using detector-row ma-
chines (Philips Medical Systems, Cleveland, OH) with an
intravenous nonionic contrast material (2 mL/kg; iopro-
mide, Ultravist 370: Bayer, Berlin, Germany). Axial and
coronal images were reconstructed with 4 mm thickness
at 3 mm intervals. Magnetic resonance (MR) imaging
was conducted using a 1.5 Tesla system (Gyroscan
Intera; Philips, Healthcare, Best, the Netherlands) or a 3
Tesla system (Achieva; Philips, Healthcare, Best, the
Netherlands) with a SENSE (sensitivity encoding) head
coil. T1- and T2-weighted imaging were performed to
evaluate the orbit including extraocular muscles. Abnor-
malities in orbital contents including the extraocular
muscles were reviewed.
All four patients with IgG4-RD showed marked en-
largement of the extraocular muscles: horizontal muscles
in all of them, vertical muscles in three of them, and the
inferior oblique muscle in one of them (Case 3) (Table 1)
(Figs. 1-4). However, despite the enlargement of extrao-
cular muscles, Cases 1–3 showed no apparent limitation
of ductions and versions (Figs. 1-3). Cases 1 and 2
showed orthotropia, and Case 3 showed a small angle of
exotropia and hypertropia < 5 prism diopters (Δ). Case 4
initially showed orthotropia, then developed hypertropia
up to 35 Δ with active inflammation of marked edema
and redness of the right upper and lower eyelids, which
promptly improved to orthotropia after treatment with
oral steroids (Fig. 4). On CT or MR images of the 4 pa-
tients with IgG4-ROD, marked enlargement of the
extraocular muscles were observed (Table 1) (Figs. 1-4).
In addition to extraocular muscle involvement, all of
them showed enlargement of unilateral or bilateral lacri-
mal glands (Table 1) (Figs. 1-4). Two of them showed
other organ involvement such as kidney, lung, or pituit-
ary stalks (Table 1).
Case 1
A 58-year-old man was referred for ophthalmologic
evaluation by the rheumatology department with the
diagnosis of IgG4-RD after submandibular gland biopsy
showing increased IgG4+ cells (> 200 cells/HPF). Serum
IgG4 level was elevated to 1295.0 mg/dL (normal range,
6.1~ 121.4) at the time of diagnosis.
On examination, his uncorrected visual acuities were
20/20 OU. He had orthotropia at distance and at near in
the primary position with the alternate prism and cover
test (Fig. 1a). Ductions and versions were full without
limitation (Fig. 1a). Exophthalmometry showed 14.5 mm
OU. He remained orthotropic until the last follow-up
examination one year later.
Orbit CT images showed enlargement of lymph nodes
in both peribronchial areas and right level I/III, right su-
perior rectus, right medial rectus, left lateral rectus, and
left inferior rectus muscles (Figs. 1b-d), and infiltrative
lesions in both lungs and perirenal space.
Case 2
A 62-year-old woman presented with left upper eyelid
swelling which developed 1 year ago. She also had expe-
rienced recurrent conjunctival injection for 3 years.
On examination, her uncorrected visual acuities were
20/20 OU. She had orthotropia at distance and at near
in the primary position with the alternate prism and
cover test (Fig. 2a). Ductions and versions were full.
Marginal reflex distances (MRD) were + 3 OD and + 2
OS. Exophthalmometry showed 16.5 mm OD and
18 mm OS.
Orbit CT showed a 2.5 cm sized enhancing mass in
the left lacrimal gland and enlargement of the left lateral
rectus muscle belly like a spindle shaped mass
Table 1 Clinical characteristics of four patients with IgG4-related disease
Case No Age(yr)/Sex VOD VOS Primary
deviation (Δ)
Affected EOM D/V Other involvement
1 58/M 20/20 20/20 Orthotropia RSR, RMR,
LLR, LIR
full B) Lacrimal gland, peribronchial area, lung,
perirenal space, pituitary stalk
2 62/F 20/20 20/20 Orthotropia LLR full L) Lacrimal gland
3 66/M 20/30 20/30 XT 4Δ RHT 3Δ RMR, RLR,
RIR, RIO
full L) Lacrimal gland






2nd: R) -3 down,
− 2 add, − 1 abd
B) Lacrimal gland, foramen rotundum,
infraorbital foramen (perineural spread along
trigeminal nerve), skullbase, parotid gland, lung
yr years; EOM extraocular muscles; R right eye; L left eye; SR superior rectus; MR medial rectus; LR lateral rectus; IR inferior rectus; IO, inferior oblique; D/V ductions/
versions; M male; F female; B both eyes; Δ prism diopters; XT exotropia; HT hypertropia; add adduction; abd abduction
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(Figs. 2b-d). Anterior orbitotomy and lacrimal gland bi-
opsy showed increased positive IgG4 cells (> 30–50
cells/HPF) and positive CD3, CD20 and Ki-67. Serum
IgG4 level was 74.0 mg/dL (normal range, 6.1~ 121.4)
and IgG2 level was 770.0 mg/dL (165–545). He was di-
agnosed with IgG4-ROD and treated with oral steroids.
Case 3
A 66-year-old man was referred from the outside hos-
pital for further evaluation of enlarged extraocular mus-
cles which were incidentally found on CT during
evaluation of sinusitis.
On examination, his corrected visual acuities were 20/
30 OU. Automatic refraction showed + 0.00 Dsph − 0.25
Dcyl x 110A OD and + 0.25 Dsph − 1.00 Dcyl x 75A OS.
He showed 4 Δ of exotropia (XT) and 3 Δ of right
hypertropia (RHT) in the primary position, XT 4 Δ and
RHT 3 Δ in right gaze, XT 2 Δ and RHT 3 Δ in left gaze,
XT 2Δ and RHT 4 Δ in upgaze, and RHT 1 Δ in down-
gaze. With either right or left head tilt, he showed XT 2 Δ
and RHT 3 Δ. Ductions and versions were full (Fig. 3a).
He had intermittent diplopia. MRD were + 2 mm OU.
Exophthalmometry showed 18 mm OD and 16.5 mm OS.
Orbit MR imaging showed enlargement of the left lac-
rimal gland, right medial rectus, right inferior rectus,
right lateral rectus, and right inferior oblique with nodu-
lar components (Figs. 3b-d). Serum IgG4 level was ele-
vated to 429.0 mg/dL (normal range, 6.1~ 121.4).
Anterior orbitotomy and lacrimal gland biopsy showed
increased positive IgG4 cells (> 50–70 cells/HPF), and
focally positive CD3, CD20 and Ki-67 (6%). He was diag-
nosed with IgG4-ROD and treated with oral steroids.
Fig. 1 Case 1. a) Ocular versions demonstrating full versions in both eyes. b, c) Orbit CT images showed enlargement of right superior rectus, right
medial rectus, left lateral rectus, and left inferior rectus muscles (arrows)
Fig. 2 Case 2. a) She showed orthotropia at distance and at near in the primary position. b, c) Orbit CT images showed a 2.5 cm sized enhancing
mass in the left lacrimal gland (arrow) and enlargement of the left lateral rectus muscle belly (asterisk) like a spindle shaped mass
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Case 4
A 74-year-old man presented with right exophthalmos
which suddenly developed 15 days ago. On examination,
his best corrected visual acuities were 20/30 OD and 20/
100 OS. Automatic refraction showed + 1.00 Dsph − 0.50
Dcyl x 180A OD and − 2.00 Dsph − 0.50 Dcyl x 180A OS.
Slit lamp examination showed left posterior capsular opa-
city. He had orthotropia at distance and at near in the
primary position with the alternate prism and cover test
(Fig. 4a). Ductions and versions were full (Fig. 4a).
Exophthalmometry showed 23 mm OD and 18.5 mm OS.
Orbit MR imaging showed an infiltrating mass involv-
ing both orbits, especially the lacrimal gland and both
lateral rectus muscles, foramen rotundum, infraobital
groove and foramen (Figs. 4b-c), trigeminal nerve, and
midline anterior skullbase. Multiple enlarged lymph
nodes were found in bilateral parotid glands, level I/II,
and mediastinum with peribronchial infiltration in the
right upper lung. Serum IgG4 level was 13.3 mg/dL.
Right anterior orbitotomy and lacrimal gland biopsy
showed lymphoplasmacytic infiltration with increased
IgG4-positive cells (> 50–100 cells/HPF, IgG4/IgG ratio >
80%), consistent with IgG4-ROD.
Three years later, he presented with right facial edema
(Fig. 4d), itching, right visual decrease, and vertical dip-
lopia. On examination, his best corrected visual acuities
were 20/50 OD and 20/100 OS. He had 10 Δ of XT and
35 Δ of RHT in the primary position, XT 4 Δ and RHT
25 Δ in right gaze, XT 10 Δ and RHT 20 Δ in left gaze,
XT 10 Δ and RHT 35 Δ in upgaze, and XT 10 Δ and
RHT 25 Δ in downgaze. With right or left head tilt, he
showed XT 10 Δ and RHT 35 Δ. Ductions and versions
showed − 3 limitation of downgaze, − 2 limitation of ad-
duction, and − 1 limitation of abduction in the right eye
(Fig. 4d). Serum IgG4 level was elevated to 788.0 mg/dL.
One month later after taking oral prednisolone 20 mg
a day, diplopia resolved and he showed orthotropia at
distance and at near in the primary position with alter-
nate prism and cover test (Fig. 4e). Ductions and ver-
sions were full (Fig. 4e). Orbit MR imaging showed a
decreased extent of infiltrative mass-forming lesions in
both orbits, especially in both lacrimal glands. However,
significant remnant mass lesions were found in the right
inferior extraconal space involving the right medial, lat-
eral, and inferior rectus muscles, left lateral, and inferior
rectus muscles, with perineural spread along both for-
amen rotundum and infraorbital foramen. Three months
later after taking oral prednisolone, serum IgG4 level de-
creased to 249.9 mg/dL.
Discussion
Our four cases demonstrated the characteristic clinical
features of eye motility associated with IgG4-ROD.
Firstly, despite marked enlargement of extraocular mus-
cles, patients maintained orthotropia with full ductions/
versions. In other words, a distinctive disparity between
structure (enlargement of extraocular muscles) and
Fig. 3 Case 3. a) Ocular versions demonstrating full versions in both eyes. b, c) Orbit MR imaging showed enlargement of the left lacrimal gland
(arrow), right medial rectus, right inferior rectus, right lateral rectus, and right inferior oblique (asterisk) with nodular components
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function (eye movement) may suggest IgG4-ROD. Thus,
we can not exclude extraocular muscle involvement even
though a patient with IgG4-RD does not have diplopia
or eye movement abnormalities. Secondly, active
flare-up of inflammation may cause a large angle of ocu-
lar deviation with underaction of the extraocular
muscles as in idiopathic myositis. Similarly, the deviation
as well as the underaction may promptly respond to oral
steroid treatment. Thirdly, all of our patients showed en-
largement of the lateral rectus muscle which is the least
affected muscle in thyroid orbitopathy. Fourthly, trigem-
inal nerve enlargement was also observed, which is not
usually involved in other orbital inflammatory conditions
such as idiopathic orbital inflammation or thyroid orbi-
topathy. Lastly, serum IgG4 level increased with the ag-
gravation of extraocular movement and decreased after
steroid treatment and symptom relief.
Serum levels of IgG4 varied widely between cases, and
though it is one of the diagnostic criteria for IgG4-ROD,
it can easily increase or decrease according to disease ac-
tivity. Case 2 and early phase of case 4 showed normal
levels of serum IgG4; however they were firmly diag-
nosed with IgG4-ROD, according to their typical im-
aging and histopathologic findings based on the
diagnostic criteria for IgG4-ROD [16].
There have been many reports of extraocular muscle
involvement associated with IgG4-ROD, however, most
of them did not mention the affected muscles or the
clinical features of ocular motility problems [7–10].
Higashiyama et al. [11] first reported a detailed descrip-
tion of a case with swelling of the left extraocular
muscles. The patient reported diplopia on upgaze [11].
Hess chart showed a slight limitation of elevation in the
left eye. Intravenous methylprednisolone 1000 mg daily
for 3 days followed by oral prednisolone improved the
supraduction limitation after 5 months [11]. Left oph-
thalmoplegia was minimal despite severe extraocular
muscle swelling [11]. Díaz et al. [12] reported a
60-year-old woman with diplopia. Brain MRI showed
enlargement of the extraocular muscles in the left eye
[12]. Symptoms improved with steroid treatment [12].
Hussain et al. [13] presented a 48-year-old man with
binocular vertical diplopia and limited upgaze in the
right eye. Oral prednisolone starting with 80 mg daily
and tapered over 4 months resulted in rapid resolution
of symptoms and signs [13]. Interestingly, this patient
did not show any evident myositis on orbit CT [13].
Sogabe et al. [5] did not find any predilection for a
specific extraocular muscle in 16 patients with
IgG4-ROD. However, in our case series, the superior
rectus muscle was the least involved (in only 1 patient).
Koizumi et al. [14] reported thickened rectus muscles
in 6 patients: Bilateral inferior rectus muscles in two
patients, left lateral rectus, medial rectus and inferior
rectus muscles in one patient, right lateral rectus
muscle in one, left lateral rectus, superior rectus and
inferior rectus muscles in one patient, and bilateral lat-
eral rectus, right medial rectus and inferior rectus mus-
cles in one patient. Interestingly the lateral rectus
muscle was affected in all our patients [14]. Because
Fig. 4 Case 4. a) Ocular versions demonstrating full versions in both
eyes. b, c) Orbit MR imaging showed diffuse infiltrative mass in both
orbits and enlargement of both lacrimal glands, both lateral rectus
and inferior rectus muscles, infraorbital groove and foramen (arrow),
and nodules in the parotid gland (double arrow) d) Ocular versions
demonstrating − 3 limitation of downgaze, − 2 limitation of
adduction, and − 1 limitation of abduction in the right eye. e) Ocular
versions were fully recovered after treatment
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the lateral rectus muscle is the least affected muscle in
thyroid orbitopathy [17], this finding may be useful to
differentiate IgG4-ROD from thyroid eye disease.
There are many inflammatory conditions affecting
the orbital structures such as thyroid orbitopathy, idio-
pathic orbital inflammation, sarcoidosis, tuberculosis,
granulomatosis with polyangiitis, and IgG4-ROD [18].
Among them, the clinical features of eye motility
associated with thyroid orbitopathy are well known
whereas those with other conditions are not. This re-
port may be helpful to clarify that. Thyroid orbitopathy
is characterized by lid edema, retraction or lid lag, con-
junctival hyperemia, chemosis, exophthalmos, extrao-
cular muscle enlargement usually sparing the tendon,
restrictive strabismus, compressive optic neuropathy,
exposure keratopathy, and sometimes with thyroid dys-
function [17]. All of the four patients in our series did
not show any lid signs, no thyroid dysfunction, no
restrictive strabismus, or extraocular muscle enlarge-
ment involving the tendon. Idiopathic orbital inflamma-
tion is characterized by a triad of pain, ophthalmoplegia
and proptosis, and is usually diagnosed after exclusion
of other orbital diseases [19]. Ophthalmoplegia charac-
teristically shows paralysis in the acute phase and a re-
strictive pattern in the late phase [19]. Idiopathic
orbital inflammation is usually unilateral [19]. Among
our four patients, two patients showed unilateral in-
volvement. However, all of them showed full ocular ver-
sions despite extraocular muscle enlargement, except
Case 4 in his second attack. Therefore, this odd dis-
crepancy between extraocular muscle involvement and
ocular motility is very helpful for the differential diag-
nosis of extraocular muscle enlargement.
Conclusion
IgG4-ROD usually shows normal ocular motility despite
extraocular muscle enlargement, which is the key distin-
guishing feature from other orbital inflammatory dis-
eases. The lateral rectus muscle is frequently involved
and may also accompany trigeminal nerve enlargement.
Some of them may develop a large angle of eye deviation
with active flare-up of inflammation and increased
serum IgG4 levels, but ocular motility mostly improves
after steroid treatment.
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